FDA Drug Safety Communication： FDA review finds additional data supports the potential for increased long-term risks with antibiotic clarithromycin（Biaxin） in patients with heart disease

相关推荐

• Telomere shortening in patients on long-term hemodialysis
• Long-term fatigue state in postoperative patients with breast cancer
• Long-term outcomes in patients with arrhythmogenic right ventricular cardiomyopathy
• Evaluating the safety of early surgery for ruptured intracranial aneurysms in patients with long-term aspirin use: a propensity score matching study
• Long-term outcomes in patients initially responsive to selective laser trabeculoplasty

同分类资源 更多

• [药学] 施行责任助产对产房护理质量的影响刘扬
• [药学] Box-Behnken效应面法优化磷酸西格列汀片处方设计
• [药学] 多西他赛联合卡铂治疗晚期非小细胞肺癌的疗效观察
• [药学] 新技术与新辅料在口服时间控制释药系统中的应用
• [药学] 论基因工程的一类新药-成纤维细胞生长因子的发展与临床应用

相关关键词